Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Abeona Therapeutics Inc. (ABEO) is a Biotechnology company based in US with a market capitalization of $372.2M. Free cash flow was negative at -$84.3M. This page tracks ABEO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 136 employees · IPO Sep 19, 1980
Valuation
Valuation & price
$5.60as of May 15, 2026· -23.2% vs 52w high
5.2
P/E ratio
Latest-FY diluted EPS
2.34
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$372.2M
Market cap
—
Revenue growth (YoY)
73.7%
Gross margin
-$84.3M
Free cash flow (USD)
-$166.4M
Net debt
Net cash position
29.0%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
14
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 22, 2026Filing
Insider Sell $10KVazzano Joseph Walter · Chief Financial Officer · $9.7K
- Insider sellJul 9, 2026Filing
Insider Sell $84KO'Malley Brendan M. · SVP, Chief Legal Officer · $83.9K
- Insider sellJul 9, 2026Filing
Insider Sell $473KSeshadri Vishwas · Director, Chief Executive Officer · $473.3K
- Insider sellJul 9, 2026Filing
Insider Sell $173KVazzano Joseph Walter · Chief Financial Officer · $173.3K
- Insider sellJul 9, 2026Filing
Insider Sell $88KVasanthavada Madhav · Chief Commercial Officer · $87.8K
- Insider sellJul 2, 2026Filing
Insider Sell $65KAlland Leila · Director · $65.1K
- Insider sellJun 15, 2026Filing
Insider Sell $104KSilverstein Christine Berni · Director · $103.7K
- 8-K eventJun 12, 2026Filing
Director Resignation
- 8-K eventJun 12, 2026Filing
Annual Meeting Results
- 8-K eventJun 10, 2026Filing
Investor Presentation Update
Questions
Frequently asked questions
What is Abeona Therapeutics Inc.'s market cap?
Abeona Therapeutics Inc. (ABEO) has a market capitalization of $372.2M.
What is ABEO's P/E ratio?
ABEO trades at a price-to-earnings ratio of 5.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is ABEO's price-to-book (P/B) ratio?
ABEO trades at 2.34 times book value per share.
Are insiders buying ABEO stock?
SEC Form 4 filings show no open-market insider buys at Abeona Therapeutics Inc. in the last 90 days (14 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.